Biodesix, Inc. logo — Leading Diagnostic Solutions Company | Nasdaq: BDSX | 2026 &...

Biodesix, Inc.

Leading Diagnostic Solutions Company | Nasdaq: BDSX | 2026 & 2025 & 2024 Top Workplaces Award Winner

Founded 2006 United States Louisville, United States 356 employees Post Ipo Equity Total: $312.49M Biotechnology, Health Care

General Information

Company Name Biodesix, Inc.
Founded Year 2006
Location United States Louisville, United States +2
Founders / Decision Makers
Team member Team member
Employees 356
Industries Biotechnology, Health Care
Funding Stage Post Ipo Equity
Social

Get notified when Biodesix, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Biodesix, Inc.

Biodesix, Inc. is a leading diagnostic solutions company in the realms of biotechnology and health care. Since its founding in 2005, the company has firmly established itself as a leader in diagnostic solutions, offering a range of Medicare-covered tests for lung cancer within the oncology healthcare continuum. Their portfolio of patented technologies, science, and processes has positioned them as a key player in the industry, making them an attractive partner for Biopharma companies. Their expertise spans across areas such as proteomics, genomics, liquid biopsy, and more, indicating their commitment to advanced and innovative practices. In April 2024, Biodesix, Inc. received a notable $55.00M Post-IPO Equity investment, showcasing a strong market interest in the company's endeavors. As a United States-based company, Biodesix, Inc. continues to make significant strides in the fields of biopharma, biotech, and lifesciences.

Taxonomy: diagnostic solutions, lung cancer, oncology, biopharma services, proteomics, genomics, liquid biopsy, biotech, lifesciences, molecular diagnostics, companion diagnostics, mass spectrometry analysis, biomarkers, clinical trials, multi-omics

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 05 Apr 2024
Post-IPO Debt •••••• 1
Investor
16 Nov 2022
Post-IPO Equity •••••• - 07 Apr 2022
Post-IPO Equity •••••• 1
Investor
07 Mar 2022
Venture Round •••••• - 01 Oct 2020

View All 15 Funding Rounds

Biodesix, Inc. Alternatives & Competitors

Biodesix, Inc. vs
Daktari Diagnostics
Daktari Diagnostics United States

Delivering critical diagnostic solutions to resource-poor markets with a commitment to quality, affo...

Grant
7 employees
Biotechnology, Health Care
Biodesix, Inc. vs
Quest Diagnostics
Quest Diagnostics United States

Working together to create a healthier world, one life at a time.

IPO
33096 employees
Biotechnology, Health Care
Biodesix, Inc. vs
SEKISUI Diagnostics
SEKISUI Diagnostics United States

Because Every Result Matters

493 employees
Health Care, Manufacturing

FAQ About Biodesix, Inc.

Leading Diagnostic Solutions Company | Nasdaq: BDSX | 2026 & 2025 & 2024 Top Workplaces Award Winner
Biodesix, Inc. was founded in 2006.
Biodesix, Inc. is headquartered in Louisville, United States.
Biodesix, Inc. operates in the following industries: Biotechnology, Health Care.
Biodesix, Inc. has approximately 356 employees.
Biodesix, Inc. has completed 15 funding rounds, raising a total of $312.49M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Biodesix, Inc. include Daktari Diagnostics, Quest Diagnostics, SEKISUI Diagnostics, Bridge Diagnostics, Veracyte, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Biodesix, Inc. and Daktari Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Biodesix, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy